ECUPHARMA
ARD COGITON LONG TIME 20 CAPSULES 520 MG
ARD COGITON LONG TIME 20 CAPSULES 520 MG
Secure payment
Discreet and sanitized package
Fast and safe shipping
Description
Description
AR D Cogiton
long time
Food supplement.
Ginkgo biloba and B vitamins help maintain normal cognitive function. Selenium, vitamin C, and vitamin E help protect cells from oxidative stress and contribute to a healthy immune system.
Ingredients
Ginkgo biloba, Vitamins CEB, Selenium, L-Cysteine, Carnosine, Coenzyme Q10, beta-carotene.
How to use
We recommend taking one capsule a day with half a glass of water.
Warnings
If taking anticoagulants or antiplatelet drugs, it is advisable to consult your doctor. Do not take during pregnancy or breastfeeding. Keep out of reach of children under three years of age. Supplements should not be used as a substitute for a varied and balanced diet and a healthy lifestyle.
Format
Box of 20 capsules of 520 mg
ECUPHARMA
ARD COGITON LONG TIME 20 CAPSULES 520 MG
ARD COGITON LONG TIME 20 CAPSULES 520 MG
Couldn't load pickup availability
Product images are purely indicative and may not be fully representative of the packaging and product features, as they may vary in color, size, or content. Any decorations, gift wrapping, and items included in the images for product presentation purposes will not be shipped with orders. Product names, ingredients, and percentages indicated in the descriptions are purely indicative and may be subject to change or updates by the manufacturers. Due to the impossibility of updating these updates in real time, the photos and technical information of the products listed on farmaInnovation.it may differ from those shown on the label or otherwise disclosed by the manufacturers. The only identifying element is the MINSAN (Ministry of Health) code. Farmacia Barni, farmainnovation.it , does not guarantee the accuracy and timeliness of the information published and declines all responsibility for any errors, omissions, or failure to update it. farmainnovation.it assumes no responsibility for damages of any kind that may arise from accessing the published information.
